Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Calbo

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Antibiotics (Basel, Switzerland)|August 28, 2025
Very Early Transition to Oral Antibiotics in Uncomplicated Enterobacterales Bloodstream Infections: Effectiveness and Impact on Carbon Footprint SavingAina Mateu, Ana Martínez-Urrea, Clara Gallego, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohortCarmen Peña, Cristina Suarez, Alain Ocampo-Sosa, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
Critical Care (London, England)|May 7, 2015
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistanceScott T Micek, Richard G Wunderink, Marin H Kollef, et al.
Journal of Infection Prevention|June 19, 2023
Late poor outcomes of <i>Clostridioides difficile</i> infections in oncological patients: A multicentre cohort studyEsther Calbo, Sergi Hernández, Nieves Sopena, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2014
Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coliVanesa Pascual, Gabriel Ortiz, Maria Simó, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2020
Applicability of Outpatient Quality Indicators for Appropriate Antibiotic Use in a Primary Health Care Area: a Point Prevalence SurveyPablo March-López, Rosa Madridejos, Rosa Tomas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2014
Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infectionsCarmen Peña, Gabriel Cabot, Silvia Gómez-Zorrilla, et al.
International Journal of Antimicrobial Agents|November 27, 2015
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolatesNoemí Alonso, Elisenda Miró, Vanesa Pascual, et al.
Emerging Infectious Diseases|October 3, 2022
Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, SpainOriol Gasch, Laia Badia-Cebada, Joao Carmezim, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Antibiotics (Basel, Switzerland)|August 28, 2025
Very Early Transition to Oral Antibiotics in Uncomplicated Enterobacterales Bloodstream Infections: Effectiveness and Impact on Carbon Footprint SavingAina Mateu, Ana Martínez-Urrea, Clara Gallego, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohortCarmen Peña, Cristina Suarez, Alain Ocampo-Sosa, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
Critical Care (London, England)|May 7, 2015
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistanceScott T Micek, Richard G Wunderink, Marin H Kollef, et al.
Journal of Infection Prevention|June 19, 2023
Late poor outcomes of <i>Clostridioides difficile</i> infections in oncological patients: A multicentre cohort studyEsther Calbo, Sergi Hernández, Nieves Sopena, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2014
Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coliVanesa Pascual, Gabriel Ortiz, Maria Simó, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2020
Applicability of Outpatient Quality Indicators for Appropriate Antibiotic Use in a Primary Health Care Area: a Point Prevalence SurveyPablo March-López, Rosa Madridejos, Rosa Tomas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2014
Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infectionsCarmen Peña, Gabriel Cabot, Silvia Gómez-Zorrilla, et al.
International Journal of Antimicrobial Agents|November 27, 2015
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolatesNoemí Alonso, Elisenda Miró, Vanesa Pascual, et al.
Emerging Infectious Diseases|October 3, 2022
Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, SpainOriol Gasch, Laia Badia-Cebada, Joao Carmezim, et al.
Pageof 8